Michael Alexander Thomashow is a San Francisco, California based male rheumatologist who is specialized in Rheumatology. Active license number of Michael Alexander Thomashow for Rheumatology is A154000 in California. Michael Alexander Thomashow treat joint disease similar to orthopedists but do not perform surgeries. He diagnose and treat diseases of joints, muscle, bones and tendons which includes arthritis, back pain, muscle strains, common athletic injuries and 'collagen' diseases.
Complete Profile:
Michael Alexander Thomashow speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Rheumatology
Gender:
Male
Practice Address:
505 Parnassus Ave, Room 987, San Francisco, California, 94143-2204
Phone:
415-476-1528
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1528420973
NPI Enumeration Date:
24 Mar, 2016
NPI Last Update On:
08 Aug, 2022
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Michael Alexander Thomashow are as mentioned below.
License Number
Specialization
State
Status
A154000
Rheumatologist
California
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
70 Beechdale Rd, Dobbs Ferry, New York
Zip:
10522-3021
Phone Number:
914-498-5295
Fax Number:
--
Patients can reach Michael Alexander Thomashow at 505 Parnassus Ave, Room 987, San Francisco, California or can call to book an appointment on 415-476-1528. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.